circCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis
- PMID: 33655888
- DOI: 10.4149/gpb_2020041
circCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis
Abstract
Neuroblastoma (NB) is an extracranial solid malignancy in childhood. More and more studies have demonstrated that circRNAs are essential regulators of various tumors. This study conducted to explore the role and mechanism of circular RNA CUT-like homeobox 1 (circCUX1) in NB. The levels of circCUX1, miR-338-3p and plant homeodomain finger protein 20 (PHF20) were detected by qRT-PCR or Western blot. Cell proliferation and apoptosis were evaluated by colony formation assay, flow cytometry and Western blot analysis. Cell migration and invasion were examined via transwell assay. Glycolysis was expressed by measuring the extracellular acidification rate (ECAR). The interaction among circCUX1, miR-338-3p and PHF20 were validated by dual-luciferase reporter assay and RNA Immunoprecipitation assay. Besides, xenograft experiment was performed to assess tumor growth in vivo. circCUX1 and PHF20 were up-regulated, while miR-338-3p was down-regulated in NB tissues and cells. Knockdown of circCUX1 suppressed the progression and glycolysis of NB cells. circCUX1 triggered NB progression and glycolysis by regulating miR-338-3p. Additionally, down-regulation of miR-338-3p promoted NB progression and glycolysis via targeting PHF20. Moreover, circCUX1 sponged miR-338-3p to regulate PHF20 expression. Furthermore, circCUX1 silencing hindered tumor growth in vivo. circCUX1 depletion suppressed tumor progression and glycolysis in NB by regulating miR-338-3p/PHF20 axis, suggesting a potential biomarker for NB treatment.
Similar articles
-
Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis.Neurochem Res. 2020 Dec;45(12):2840-2855. doi: 10.1007/s11064-020-03132-w. Epub 2020 Sep 30. Neurochem Res. 2020. PMID: 33000435
-
SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.Neurochem Res. 2020 Apr;45(4):825-836. doi: 10.1007/s11064-020-02955-x. Epub 2020 Jan 9. Neurochem Res. 2020. PMID: 31919621
-
LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.Biomed Pharmacother. 2020 Sep;129:110268. doi: 10.1016/j.biopha.2020.110268. Epub 2020 Jun 17. Biomed Pharmacother. 2020. PMID: 32563146
-
Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p.Biomed Pharmacother. 2020 Aug;128:110293. doi: 10.1016/j.biopha.2020.110293. Epub 2020 Jun 10. Biomed Pharmacother. 2020. PMID: 32534305
-
The roles of microRNAs in neuroblastoma.World J Pediatr. 2014 Feb;10(1):10-6. doi: 10.1007/s12519-014-0448-2. Epub 2014 Jan 25. World J Pediatr. 2014. PMID: 24464658 Review.
Cited by
-
Epigenetic modification mediated by PHF20/METTL14/HOXA13 signaling axis modulates osteogenic differentiation of mesenchymal stem cells.Funct Integr Genomics. 2025 Jan 6;25(1):7. doi: 10.1007/s10142-024-01516-7. Funct Integr Genomics. 2025. PMID: 39757292
-
PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.Biochem Genet. 2023 Aug;61(4):1369-1386. doi: 10.1007/s10528-022-10321-5. Epub 2023 Jan 4. Biochem Genet. 2023. PMID: 36598702
-
Recent advances and application value of circRNA in neuroblastoma.Front Oncol. 2023 Apr 6;13:1180300. doi: 10.3389/fonc.2023.1180300. eCollection 2023. Front Oncol. 2023. PMID: 37091173 Free PMC article. Review.
-
An Update on Circular RNA in Pediatric Cancers.Biomedicines. 2022 Dec 23;11(1):36. doi: 10.3390/biomedicines11010036. Biomedicines. 2022. PMID: 36672544 Free PMC article. Review.
-
Role of non-coding RNAs in neuroblastoma.Cancer Gene Ther. 2023 Sep;30(9):1190-1208. doi: 10.1038/s41417-023-00623-0. Epub 2023 May 22. Cancer Gene Ther. 2023. PMID: 37217790 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials